Skip to main content

ValueAct Loves Itself Some James Gorman

The Morgan Stanley CEO is safe in this activist hedge fund's arms.
  • Author:
  • Updated:
(Getty Images)

Getty Images

Jeffrey Ubben may not exactly be Dan Loeb when it comes to correspondence. But, as an activist investor, it should suffice to say that the ValueAct Capital chief isn’t used to writing love letters. But when he lays eyes upon the rugged Australian visage of Morgan Stanley CEO Jim Gorman, he just can’t help himself. Nor can he figure out what the hell is wrong with everyone else, who don’t see Gorman’s genius—the record number of firings, the advisory business’ growth, the telling employees what he really thinks of them. But if the morons in the market want to give Ubben a value opportunity—one that probably won’t even run afoul of regulators.

ValueAct Capital Management’s investment in Morgan Stanley is a striking vote of confidence in the Wall Street institution—one that could signal a broader shift in investor perceptions of major banks. The $1.1 billion outlay, for around 2% of Morgan Stanley, is unusual in a few ways: ValueAct isn’t urging big changes in strategy or management. Instead, it is essentially endorsing Chief Executive James Gorman’s strategy. This fits with ValueAct’s general practice of acting as a friendly, rather than hostile, activist investor.

ValueAct Places $1.1 Billion Bet on Morgan Stanley [WSJ]
ValueAct Says ‘More Please’ at Morgan Stanley [WSJ]


(Getty Images)

James Gorman Has A Nifty New Euphemism For ‘Pay Cut’

Morgan Stanley decides compensation is only for closers.

(Getty Images)

James Gorman Is Not Amused

What the hell is wrong with you people?

Getty Images

Paranoia Pays Off For James Gorman

Morgan Stanley paid $124 million to make people go away and still set profit records.

(Getty Images)

James Gorman Introduces The Denver Discount

“If you want to get paid New York rates, you work in New York.”